Medidata Medidata



Dial down risk while you dial up efficiency, flexibility, and start-up speed.

Meet Rave RTSM, Medidata’s innovative randomization and trial supply management system. Rave RTSM seamlessly integrates with Rave EDC to eliminate duplicate data entry, reduce reconciliation, decrease administrative burden associated with traditional methods of specifications, and significantly lower your risk and cost. It’s completely configurable with pre-validated components so you can get your study started faster. Our innovative Edit Live Design™ functionality enables adaptive trials, makes managing complex study set-ups easier and simplifies mid-study changes.

Eliminate data reconciliation. Simplify changes. Decrease start-up time.

Why Rave RTSM?

The Only RTSM Unified with Rave

With a seamless, user-friendly interface and streamlined workflow, Rave RTSM is completely unified with Rave EDC. Rave RTSM provides eSA (electronic supply accountability) enabling users to perform IP (investigational product) accountability and reconciliation seamlessly within Rave EDC. Close out your study faster, complete site eCRFs an average of 35 percent faster, and reduce data entry costs dramatically. And because Rave RTSM is cloud-based, your team can access secure data anytime, anywhere.

The Only RTSM That’s 100 Percent Configurable

Using pre-validated components, you can quickly create the system that’s right for your study, even for complex, variable trial designs. With Rave RTSM, you can start your study in two to three weeks versus the industry standard of six-plus weeks.

The Only RTSM That Provides Real-Time Flexibility

Rave RTSM offers unrivaled flexibility for your trial. Make mid-study changes in real time, without time-consuming change orders. The first capability of its kind in the industry, Edit Live Design enables adaptive trials, re-randomization, and comprehensive supply management schemes that require changes on demand.

Proven by More Than 1,000 Clinical Trials

The Rave RTSM randomization algorithms are designed by our expert statisticians and have been used in more than 1,000 clinical trials across multiple therapeutic areas; involving more than 230,000 patients since 2010.

Accurately and efficiently randomizing patients and supplying treatments is at the very heart of clinical trials.

Getting the most out of the Medidata Rave Clinical Cloud with Rave RTSM.

Start studies faster with randomization you can trust, enabled by Rave eConsent, Rave eCOA, Rave EDC, and Rave RTSM.

Patients are auto-enrolled and consented with Rave eConsent, and randomized using Rave RTSM in a single platform. Because Rave EDC captures randomization and dosing criteria, you can automatically determine if and when a patient should be randomized and/or dosed. This approach eliminates the need for multiple data entry and helps ensure the right treatment is delivered to the right patient at the right time.

See the benefits and experience of using Rave RTSM for a randomized, double-blinded trial with Cancer Research UK.